ATC Group: G02CX Other gynecologicals

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G02CX in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G02 Other gynecologicals
3 G02C Other gynecologicals
4 G02CX Other gynecologicals

Group G02CX contents

Code Title
G02CX01 Atosiban
G02CX02
G02CX03
G02CX04
G02CX05
G02CX06

Active ingredients in G02CX

Active Ingredient Description
Atosiban

Atosiban is a synthetic peptide which is a competitive antagonist of human oxytocin at receptor level. In human pre-term labour, atosiban at the recommended dosage antagonises uterine contractions and induces uterine quiescence.

Fezolinetant

Fezolinetant is a non-hormonal selective neurokinin 3 (NK3) receptor antagonist. It blocks neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron, which is postulated to restore the balance in KNDy neuronal activity in the thermoregulatory centre of the hypothalamus.

Flibanserin

Flibanserin is a multifunctional serotonin agonist and antagonist used for the treatment of premenopausal women with hypoactive sexual desire disorder. In vitro, flibanserin acts as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors. It also has moderate antagonist activities at the 5-HT2B, 5-HT2C, and dopamine D4 receptors.

Related product monographs

Title Information Source Document Type  
ADDYI Film coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
Tractocile 7.5 mg/ml Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TRACTOCILE Solution for injection European Medicines Agency (EU) MPI, EU: SmPC